Pregnancycategory N/A Legal status Investigational PubChem CID 9805950 | ATC code None CAS Number 447406-78-2 ChemSpider 7981710 | |
 | ||
Sodelglitazar, formerly known as GW 677954, is a thiazole PPARδ receptor agonist developed by GlaxoSmithKline. While it is primarily active at the PPARδ receptor, it is considered a pan agonist with activity at PPARα and PPARγ receptors.
Safety
Phase 2 studies were terminated prior to completion due to safety findings in rodent studies.
References
Sodelglitazar Wikipedia(Text) CC BY-SA